Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹16 Cr
Revenue (TTM)
₹492 Cr
Net Profit (TTM)
₹45 Cr
ROE
19.2 %
ROCE
17.6 %
P/E Ratio
--
P/B Ratio
0.1
Industry P/E
36.8
EV/EBITDA
10.6
Div. Yield
0 %
Debt to Equity
0.2
Book Value
₹--
EPS
₹-16.2
Face value
10
Shares outstanding
26,164,150
CFO
₹-34.39 Cr
EBITDA
₹417.39 Cr
Net Profit
₹214.45 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amar Remedies
| -81.7 | -21.2 | -12.2 | -82.6 | -60.6 | -19.1 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE FMCG#
| -15.3 | -8.8 | -13.4 | -11.5 | 1.2 | 5.8 | 8.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amar Remedies
|
6.1 | 15.9 | 491.6 | -42.4 | 4.3 | -- | -- | 0.1 |
| 360.5 | 4,711.4 | 1,088.6 | 156.8 | 15.0 | 22.6 | 29.9 | 6.8 | |
| 398.3 | 17,357.4 | 3,817.5 | 798.5 | 21.4 | 28.6 | 21.9 | 5.3 | |
| 215.3 | 494.5 | 104.9 | 13.4 | -- | 45.4 | 37 | 5.3 | |
| 208.1 | 7,645.4 | 2,892.8 | 342.7 | 14.0 | 24.5 | 22.3 | 5.0 | |
| 263.2 | 409.7 | 221.4 | -75.4 | -23.1 | -- | -- | -3.1 | |
| 46.2 | 89.5 | 308.8 | 3.9 | 1.5 | 10.9 | 23.3 | 2.4 | |
| 62.6 | 152.4 | 392.0 | -4.7 | 0.9 | -2.7 | -- | 0.9 | |
| 319.4 | 649.7 | 107.5 | 16.0 | -- | 29.6 | 40.7 | 5.3 | |
| 443.1 | 13,898.9 | 3,389.4 | 207.1 | 9.5 | 4.4 | 67.1 | 2.5 |
No Review & Analysis are available.
Manufacture of preparations for oral or dental hygiene (includes manufacture of toothpastes, toothpowder, mouthwash, oral, perfumes, dental fixative pastes and powders etc.)
Incorporated
1984
Chairman
Pravin Shah
Managing Director
Sagar P Shah
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Amar Remedies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsLimited Review for June 30, 2013
19-Aug-2013Financial Results for June 30, 2013
16-Aug-2013
The share price of Amar Remedies Ltd is ₹6.07 (BSE) and ₹5.80 (NSE) as of 11-Dec-2013 IST. Amar Remedies Ltd has given a return of -60.59% in the last 3 years.
Since, TTM earnings of Amar Remedies Ltd is negative, P/E ratio is not available.
The P/B ratio of Amar Remedies Ltd is 0.07 times as on 11-Dec-2013, a 99 discount to its peers’ median range of 6.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2012
|
7.76
|
1.35
|
|
2011
|
6.80
|
1.24
|
|
2010
|
6.14
|
1.14
|
|
2009
|
2.77
|
0.50
|
|
2008
|
3.07
|
0.54
|
The 52-week high and low of Amar Remedies Ltd are Rs -- and Rs -- as of 02-Apr-2026.
Amar Remedies Ltd has a market capitalisation of ₹ 16 Cr as on 11-Dec-2013. As per SEBI classification, it is a company.
Before investing in Amar Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.03
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.